This content is from: Patents
In-house roundup: anti-anti-suit injunction filers reveal insights; US-UK trade documents unpacked; open source case spurs NPE fear
Managing IP rounds up the latest news and analysis from patent-focused businesses
Anti-anti-suit injunctions: filers reveal importance of new orders
IPCom, Nokia and two car companies say the success of the new order shows that forum-shopping does not fly with European courts and – if that continues – anti-suit injunctions will not become popular as a ‘stalling tool’. Read more...What the US-UK trade deal documents actually reveal
Generics and innovator sources from the pharma industry explain why documents from US and UK trade discussions do not point to the US trying to extend pharmaceutical patents. Read more...Open source case prompts patent troll litigation fears
Software stakeholders including the Linux Foundation, Qualcomm and Unified Patents are concerned that RPI v Gnome has opened the door to open source NPE litigation. Read more...Dismantling the patent system not a 'silver bullet' to lower drug prices
In-house counsel from pharma innovators say the IP system is unfairly under attack for rising drug prices and that new drugs will not reach the market without patents. Read more...The material on this site is for law firms, companies and other IP specialists. It is for information only. Please read our Terms and Conditions and Privacy Notice before using the site. All material subject to strictly enforced copyright laws.
© 2021 Euromoney Institutional Investor PLC. For help please see our FAQs.